Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial
DiscussionThis is the first trial to compare the impact of different therapeutic paracentesis strategies on organ dysfunction and outcomes in the prevention and treatment of IAH in critically ill patients with cirrhosis and ascites.Trial registrationClinicalTrials.govNCT04322201. Registered on 20 December 2019 (Source: Trials)
Source: Trials - August 15, 2023 Category: Research Source Type: clinical trials
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Condition: Acute-On-Chronic Liver Failure Interventions: Drug: 3 times hUC-MSC and 2 times placebo; Drug: 3 times hUC-MSC and 2 times hUC-MSC; Drug: Placebo Sponsors: Beijing 302 Hospital; Shulan (Hang Zhou) Hospital; BeijingYouan Hospital; Shenzhen Third People's Hospital; Shen Zhen Wingor Biotechnology CO. LTD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Condition: Acute-On-Chronic Liver Failure Interventions: Drug: standard medical treatment; Drug: hUC-MSC at week0; Drug: Placebo at week0; Drug: hUC-MSC at week1; Drug: Placebo at week1; Drug: hUC-MSC at week2; Drug: Placebo at week2; Drug: hUC-MSC at week4; Drug: Placebo at week4; Drug: hUC-MSC at week5; Drug: Placebo at week5 Sponsors: Beijing 302 Hospital; Shulan (Hang Zhou) Hospital; BeijingYouan Hospital; Shenzhen Third People's Hospital; Shen Zhen Wingor Biotechnology CO. LTD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Correction: End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial —HOPExt
(Source: Trials)
Source: Trials - August 14, 2023 Category: Research Source Type: clinical trials
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Condition: Acute-On-Chronic Liver Failure Interventions: Drug: 3 times hUC-MSC and 2 times placebo; Drug: 3 times hUC-MSC and 2 times hUC-MSC; Drug: Placebo Sponsors: Beijing 302 Hospital; Shulan (Hang Zhou) Hospital; BeijingYouan Hospital; Shenzhen Third People's Hospital; Shen Zhen Wingor Biotechnology CO. LTD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
Disparities Among Liver Transplant Patients
Condition: End Stage Liver DIsease Intervention: Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
